Can-Fite Biopharma Shares Outstanding 2012-2019 | CANF

Can-Fite Biopharma shares outstanding from 2012 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Can-Fite Biopharma Annual Shares Outstanding
(Millions of Shares)
2018 1
2017 1
2016 1
2015 1
2014 1
2013 0
2012
2011 0
Can-Fite Biopharma Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 23
Q4 2018
Q1 2018 17
Q1 2017 1
Q1 2016 1
Q4 2015 0
Q3 2015 1
Q2 2015 1
Q1 2015 1
Q4 2014 1
Q3 2014 0
Q2 2014 1
Q1 2014 1
Q4 2013 0
Q3 2013 0
Q2 2013 0
Q1 2013 0
Q3 2012 0
Q2 2012 0
Q1 2012 0
Q4 2011
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.004B $0.004B
Can Fite Biopharma Ltd. is a biopharmaceutical company. It is focused on developing drugs for the treatment of cancer and autoimmune inflammatory diseases. The Company's lead drug candidate, CF101, is in clinical development for the treatment of autoimmune inflammatory diseases. Its CF102 drug candidate is being developed for the treatment of liver diseases and its CF602 drug is being developed for the treatment of inflammation and sexual dysfunction. Can Fite Biopharma Ltd. is based in Petach Tikva, Israel.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.318B 34.70
Astellas Pharma (ALPMY) Japan $28.136B 13.80
Takeda Pharmaceutical (TAK) Japan $27.904B 8.19
UCB SA (UCBJF) Belgium $15.866B 0.00
Eisai (ESALY) Japan $15.830B 27.22
Grifols, S.A (GRFS) Spain $15.051B 19.03
Merck (MKGAF) Germany $13.273B 18.11
IPSEN SA ADR (IPSEY) France $10.783B 0.00
Ionis Pharmaceuticals (IONS) United States $9.487B 20.74
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Sage Therapeutics (SAGE) United States $9.220B 0.00
Neurocrine Biosciences (NBIX) United States $7.950B 0.00
Catalent (CTLT) United States $7.831B 31.43
Jazz Pharmaceuticals (JAZZ) Ireland $7.737B 10.61
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Nektar Therapeutics (NKTR) United States $5.663B 9.23
STADA ARZNEIMI (STDAF) Germany $5.634B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.420B 0.00
Orion OYJ (ORINY) Finland $5.275B 24.34
Hypermarcas (HYPMY) Brazil $4.786B 16.82
Tilray (TLRY) Canada $4.318B 0.00
Evotec AG (EVTCY) Germany $4.265B 45.78
FibroGen (FGEN) United States $4.003B 0.00
United Therapeutics (UTHR) United States $3.326B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.177B 11.40
Arrowhead Pharmaceuticals (ARWR) United States $2.670B 402.29
Xencor (XNCR) United States $2.517B 68.71
PTC Therapeutics (PTCT) United States $2.512B 0.00
Zogenix (ZGNX) United States $2.004B 0.00
Portola Pharmaceuticals (PTLA) United States $1.749B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.689B 81.82
Ironwood Pharmaceuticals (IRWD) United States $1.614B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.604B 21.92
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Heron Therapeutics (HRTX) United States $1.482B 0.00
USANA Health Sciences (USNA) United States $1.446B 12.57
Corcept Therapeutics (CORT) United States $1.231B 17.57
ArQule (ARQL) United States $1.164B 0.00
Aerie Pharmaceuticals (AERI) United States $1.119B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.014B 0.00
Radius Health (RDUS) United States $1.010B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.977B 3.52
Spectrum Pharmaceuticals (SPPI) United States $0.880B 0.00
Endo (ENDP) Ireland $0.835B 1.34
Concordia (CXRXF) Canada $0.719B 0.00
Aptorum Group (APM) China $0.652B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.594B 0.00
TherapeuticsMD (TXMD) United States $0.591B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.584B 0.00
Organogenesis Holdings (ORGO) United States $0.576B 0.00
GlycoMimetics (GLYC) United States $0.549B 0.00
Translate Bio (TBIO) United States $0.495B 0.00
Karyopharm Therapeutics (KPTI) United States $0.481B 0.00
ChemoCentryx (CCXI) United States $0.480B 0.00
Akebia Therapeutics (AKBA) United States $0.477B 0.00
Dermira (DERM) United States $0.465B 0.00
Siga Technologies (SIGA) United States $0.461B 1.09
BioSpecifics Technologies Corp (BSTC) United States $0.458B 23.12
Dova Pharmaceuticals (DOVA) United States $0.454B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.422B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.418B 0.00
CV Sciences (CVSI) United States $0.417B 0.00
Flexion Therapeutics (FLXN) United States $0.415B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.410B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.409B 0.00
Indivior (INVVY) United States $0.401B 1.45
BioCryst Pharmaceuticals (BCRX) United States $0.393B 0.00
CannTrust Holdings (CTST) Canada $0.388B 0.00
Innate Pharma SA (IPHYF) France $0.369B 0.00
Harpoon Therapeutics (HARP) United States $0.366B 0.00
Collegium Pharmaceutical (COLL) United States $0.362B 0.00
ImmunoGen (IMGN) United States $0.341B 0.00
Xeris Pharmaceuticals (XERS) United States $0.333B 0.00
KalVista Pharmaceuticals (KALV) United States $0.297B 0.00
OptiNose (OPTN) United States $0.291B 0.00
Rafael Holdings (RFL) United States $0.287B 0.00
Molecular Templates (MTEM) United States $0.276B 0.00
Concert Pharmaceuticals (CNCE) United States $0.263B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.243B 0.00
Aratana Therapeutics (PETX) United States $0.241B 0.00
Lannett Co Inc (LCI) United States $0.227B 2.20
Ocular Therapeutix (OCUL) United States $0.222B 0.00
Recro Pharma (REPH) United States $0.221B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.220B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.215B 0.00
Redhill Biopharma (RDHL) Israel $0.184B 0.00
Calithera Biosciences (CALA) United States $0.171B 0.00
Nature's Sunshine Products (NATR) United States $0.170B 55.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.168B 0.00
IMV INC (IMV) Canada $0.166B 0.00
Taiwan Liposome (TLC) Taiwan $0.166B 0.00
Ardelyx (ARDX) United States $0.162B 0.00
MEI Pharma (MEIP) United States $0.143B 0.00
Jounce Therapeutics (JNCE) United States $0.142B 0.00
Majesco Entertainment (PTE) United States $0.136B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.128B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.124B 0.00
AgeX Therapeutics (AGE) United States $0.120B 0.00
DURECT (DRRX) United States $0.112B 0.00
Aquestive Therapeutics (AQST) United States $0.107B 0.00
Generex Biotechnology (GNBT) United States $0.099B 0.00
RENEURON GP (RNUGF) United Kingdom $0.094B 0.00
Infinity Pharmaceuticals (INFI) United States $0.094B 0.00
Genocea Biosciences (GNCA) United States $0.092B 0.00
Aclaris Therapeutics (ACRS) United States $0.091B 0.00
Mast Therapeutics (SVRA) United States $0.091B 0.00
Iterum Therapeutics (ITRM) Ireland $0.091B 0.00
Capnia (SLNO) United States $0.090B 0.00
Champions Oncology (CSBR) United States $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.089B 63.33
Avadel Pharmaceuticals (AVDL) Ireland $0.087B 0.00
MediWound (MDWD) Israel $0.087B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.084B 0.00
Cardiome Pharma (CORV) Canada $0.084B 0.00
Natural Alternatives (NAII) United States $0.082B 8.23
China SXT Pharmaceuticals (SXTC) China $0.080B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.080B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Nivalis Therapeutics (ALPN) United States $0.076B 0.00
Novan (NOVN) United States $0.075B 0.00
Pharmaxis (PXSLY) Australia $0.071B 0.00
Neos Therapeutics (NEOS) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.061B 0.00
India Globalization Capital (IGC) United States $0.060B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.053B 0.00